Patients
Already the leader in epilepsy and allergy, we're working on novel solutions for people with conditions such as Crohn's disease, multiple sclerosis and osteoporosis…
Top of this page
Skip navigation, go straight to the content
Home Page
With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on severe diseases in two therapeutic areas - CNS and Immunology. UCB also has a selective presence in primary care.
Investors
With global revenue of more than €3 billion, we have a long track record of turning novel ideas into commercial realities…
Jobseekers
Join us and make a world of difference as we build the next generation biopharma, supported by a dynamic team in over 40 countries across the globe…
Partners
A world leader in antibody research, plus a rich pipeline of large and small molecules, has attracted more than 30 partners, such as Amgen…
